148 related articles for article (PubMed ID: 7606879)
41. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
Fishbane S; Berns JS
Kidney Int; 2005 Sep; 68(3):1337-43. PubMed ID: 16105069
[TBL] [Abstract][Full Text] [Related]
42. Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients.
Greenbaum LA; Pan CG; Caley C; Nelson T; Sheth KJ
Pediatr Nephrol; 2000 Sep; 14(10-11):908-11. PubMed ID: 10975297
[TBL] [Abstract][Full Text] [Related]
43. Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin.
Hou CC; Wu SC; Wu SC; Yang WC; Huang TP; Ng YY
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):456-62. PubMed ID: 9745161
[TBL] [Abstract][Full Text] [Related]
44. Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants.
Kivivuori SM; Heikinheimo M; Teppo AM; Siimes MA
Pediatr Res; 1994 Jul; 36(1 Pt 1):85-9. PubMed ID: 7936843
[TBL] [Abstract][Full Text] [Related]
45. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
Braun J; Lindner K; Schreiber M; Heidler RA; Hörl WH
Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
[TBL] [Abstract][Full Text] [Related]
46. A randomized trial of iron deficiency testing strategies in hemodialysis patients.
Fishbane S; Shapiro W; Dutka P; Valenzuela OF; Faubert J
Kidney Int; 2001 Dec; 60(6):2406-11. PubMed ID: 11737617
[TBL] [Abstract][Full Text] [Related]
47. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project.
Frankenfield DL; Neu AM; Warady BA; Fivush BA; Johnson CA; Brem AS
Kidney Int; 2003 Sep; 64(3):1120-4. PubMed ID: 12911565
[TBL] [Abstract][Full Text] [Related]
48. Effects of high-dose vitamin B6 therapy on microcytic and hypochromic anemia in hemodialysis patients.
Toriyama T; Matsuo S; Fukatsu A; Takahashi H; Sato K; Mimuro N; Kawahara H
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):975-80. PubMed ID: 8255009
[TBL] [Abstract][Full Text] [Related]
49. Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients.
Low CL; Bailie GR; Eisele G
Ren Fail; 1997 Nov; 19(6):781-8. PubMed ID: 9415935
[TBL] [Abstract][Full Text] [Related]
50. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin.
Weiss G; Meusburger E; Radacher G; Garimorth K; Neyer U; Mayer G
Kidney Int; 2003 Aug; 64(2):572-8. PubMed ID: 12846752
[TBL] [Abstract][Full Text] [Related]
51. Direct effect of deferoxamine on hemoglobin synthesis in patients on hemodialysis treated with recombinant human erythropoietin.
Romero R; Novoa D; Otero S; Alonso MC; Alonso R; Arcocha V; Arza D; Lens XM; Sanchez-Guisande D
Nephron; 1993; 63(2):164-7. PubMed ID: 8450906
[TBL] [Abstract][Full Text] [Related]
52. [Humoral markers of iron status in patients on maintenance hemodialysis].
Valenti M; Bergia R; Caramello E; Dionisio P; Nerva F; Graziola M; Lanza E; Bajardi P
Minerva Med; 1986 Sep; 77(36):1605-10. PubMed ID: 3763031
[TBL] [Abstract][Full Text] [Related]
53. Biochemical markers of iron status in hemodialysis patients.
Hukic F; Nuhbegovic S; Brkic S; Ostrvica E; Custendil-Delic S; Mustafic S
Med Arh; 2010; 64(4):219-22. PubMed ID: 21246919
[TBL] [Abstract][Full Text] [Related]
54. Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron.
Ghoti H; Rachmilewitz EA; Simon-Lopez R; Gaber R; Katzir Z; Konen E; Kushnir T; Girelli D; Campostrini N; Fibach E; Goitein O
Eur J Haematol; 2012 Jul; 89(1):87-93. PubMed ID: 22435497
[TBL] [Abstract][Full Text] [Related]
55. [Serum ferritin during hemodialysis. II: Outline for iron therapy].
Marco Franco JE; Alarcón Zurita A; Morey Molina A; Pizá Buñola C; Bestard Palmer J; Mairata Bosch S; Galmés Llodra A; Dalmau Diana M
Rev Clin Esp; 1982 Jan; 164(1):11-4. PubMed ID: 7071397
[No Abstract] [Full Text] [Related]
56. Effect of weekly or successive iron supplementation on erythropoietin doses in patients receiving hemodialysis.
Kato A; Hamada M; Suzuki T; Maruyama T; Maruyama Y; Hishida A
Nephron; 2001 Sep; 89(1):110-2. PubMed ID: 11528242
[TBL] [Abstract][Full Text] [Related]
57. Increased visfatin in hemodialysis patients is associated with decreased demands for recombinant human erythropoietin.
Eleftheriadis T; Pissas G; Remoundou M; Antoniadi G; Liakopoulos V; Stefanidis I
Ren Fail; 2013; 35(10):1399-403. PubMed ID: 23964827
[TBL] [Abstract][Full Text] [Related]
58. Functional iron deficiency in hemodialysis patients with high ferritin.
Kopelman RC; Smith L; Peoples L; Biesecker R; Rizkala AR
Hemodial Int; 2007 Apr; 11(2):238-46. PubMed ID: 17403177
[TBL] [Abstract][Full Text] [Related]
59. Serum ferritin concentration in patients receiving maintenance hemodialysis.
Lynn KL; Mitchell TR; Shepperd J
Clin Nephrol; 1980 Sep; 14(3):124-7. PubMed ID: 7418278
[TBL] [Abstract][Full Text] [Related]
60. Serum ferritin and iron deficiency in patients on chronic hemodialysis.
Beallo R; Dallman PR; Schoenfeld PY; Humphreys MH
Trans Am Soc Artif Intern Organs; 1976; 22():73-9. PubMed ID: 951893
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
